Elanco Animal Health Incorporated Common Stock vs Vanguard International High Dividend Yield ETF — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.92 (market cap $11.26B), while Vanguard International High Dividend Yield ETF trades at $100.66 (market cap $22.80B). The key difference: Vanguard International High Dividend Yield ETF is far larger — about 2× Elanco Animal Health Incorporated Common Stock's market cap, and Vanguard International High Dividend Yield ETF is trading nearer its 52-week high, Elanco Animal Health Incorporated Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 1 Days and Vanguard International High Dividend Yield ETF for 50 Days on average.
| ELAN | VYMI | |
|---|---|---|
Market Cap | $11.26B | $22.80B |
Volume | 4,570,386 | 748,441 |
Sector | Health | Broad Market / Factor |
52-Week High | $26.84 | $107.13 |
52-Week Low | $19.76 | $82.92 |
Typical Hold Time | 1 Days | 50 Days |
Enterprise Value | $14.65B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VYMI trades at $100.66, up 0.43% on the day, with a bearish technical signal from moving averages but neutral oscillators. The ETF focuses on international high dividend yield stocks, with recent institutional buying activity from Envestnet and Corient Private Wealth. Recent news highlights strong performance with a 29% one-year return and 14.13% five-year average annual return, supported by financials, energy, and healthcare sector exposure.
The outlook remains positive given Vanguard's bullish stance on international developed markets and the ETF's attractive dividend yield. Key risks include global economic volatility and currency fluctuations, but institutional accumulation and sector alignment with rising rates support the investment thesis for income-focused investors seeking international diversification.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.
Read more on ELAN →VYMI is an index-based ETF that provides exposure to non-U.S. companies across developed and emerging markets that are characterized by high dividend yields. It tracks the FTSE All-World ex US High Dividend Yield Index, offering a diversified, low-cost way to capture international income while serving as a tactical hedge against U.S. market concentration.
Read more on VYMI →